Release Date: 01/06/18 16:49 Summary: Reinstatement to Official Quotation - Monday 4 June 2018 Price Sensitive: Yes Download Document 219.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%